50721-57-8 Usage
Description
1-Ethyl-1,3-diazinane-2,4,6-trione, also known as ethylisocyanoacetate, is a chemical compound with the molecular formula C6H7NO3. It is a white crystalline solid that is used as a reagent in organic synthesis, particularly in the preparation of heterocyclic compounds. It is also used as a building block for pharmaceuticals and agrochemicals. 1-ethyl-1,3-diazinane-2,4,6-trione is known for its ability to act as a versatile starting material in the preparation of various functionalized compounds, making it a valuable tool in the field of medicinal and agricultural chemistry. Additionally, it has been studied for its potential as a precursor in the development of new materials and as a building block for the synthesis of chiral compounds due to its unique structure and reactivity.
Uses
Used in Organic Synthesis:
1-Ethyl-1,3-diazinane-2,4,6-trione is used as a reagent for the preparation of heterocyclic compounds, which are important in the development of pharmaceuticals and agrochemicals.
Used in Pharmaceutical Industry:
1-Ethyl-1,3-diazinane-2,4,6-trione is used as a building block for the synthesis of pharmaceuticals, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
1-Ethyl-1,3-diazinane-2,4,6-trione is used as a building block for the synthesis of agrochemicals, aiding in the creation of new pesticides and other agricultural chemicals.
Used in the Development of New Materials:
1-Ethyl-1,3-diazinane-2,4,6-trione has been studied for its potential as a precursor in the development of new materials, showcasing its versatility and applicability in various fields.
Used in the Synthesis of Chiral Compounds:
Due to its unique structure and reactivity, 1-ethyl-1,3-diazinane-2,4,6-trione is used as a building block for the synthesis of chiral compounds, which are essential in various chemical and pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 50721-57-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,7,2 and 1 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 50721-57:
(7*5)+(6*0)+(5*7)+(4*2)+(3*1)+(2*5)+(1*7)=98
98 % 10 = 8
So 50721-57-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2O3/c1-2-8-5(10)3-4(9)7-6(8)11/h2-3H2,1H3,(H,7,9,11)
50721-57-8Relevant articles and documents
Synthesis method of 6-chloro-3-alkyl uracil
-
Paragraph 0053-0054, (2019/12/02)
The invention relates to a synthesis method of 6-chloro-3-alkyl uracil, which is characterized by comprising the following steps: by using malonic acid and N-alkyl urea as raw materials, carrying outthe cyclization reaction to generate alkyl tripyrimidone; and then carrying out chlorination on the alkyl tripyrimidone to generate the 6-chloro-3-alkyl uracil. Compared with an existing method, the method is mild in reaction and low in cost, high-cost and high-risk raw materials such as high-toxicity and high-boiling phosphorus oxychloride are not used, and industrial large-scale production is facilitated; meanwhile, the chemical purity obtained by the method is high, the yield is good, and the economic benefit is good.
HETEROCYCLYLMETHYL-THIENOURACILE AS ANTAGONISTS OF THE ADENOSINE-A2B-RECEPTOR
-
Paragraph 1240, (2018/03/25)
The present application relates to novel thieno[2,3-d]pyrimidine-2,4-dione (“thienouracil”) derivatives bearing a particular type of (azaheterocyclyl)methyl substituent, to processes for the preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of pulmonary and cardiovascular disorders and of cancer.
COMPOUNDS FOR USE IN CANCER THERAPY
-
Page/Page column 57, (2013/03/26)
Provided are methods and compositions for use in therapy, and in particular for treating cancer, preferably drug resistant cancer, and/or radiation resistant cancer. The compounds may be used for reducing tumor size in a mammalian subject and for inducing apoptosis in a tumor cell. The methods are effective on tumor cells that are resistant to drugs such as temozolomide, doxor-ubicin, and geldanamycin, as well as non-resistant tumor cells. Further provided are barbiturate and thiobarbiturates diene compounds for use in treating cancer, and uses, methods and compositions relating to these compounds
